Sun Pharma Advanced Research Co P/B Ratio

Current P/B Ratio
5.09
High Valuation
Very High - Significant premium, high growth expectations or speculative

Sun Pharma Advanced Research Co (SPARC) P/B ratio is 5.09 (High), book value per share ₹405.76 vs Healthcare average P/B of -0.33 — Very High - Significant premium, high growth expectations or speculative. Compare with Sun Pharma Advanced Research C valuation methods to assess whether the stock is under or overvalued.

Current Valuation Metrics

P/B Ratio 5.09
Current Price ₹221.35
Book Value/Share ₹405.76
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹1,339 Cr
Share Capital ₹33 Cr
Reserves & Surplus ₹1,306 Cr
Outstanding Shares 33,000,000
Book Value per Share ₹405.76

Valuation Signal

Signal Overvalued
Historical Avg 2.55
Historical Range 0.55 - 5.25
Percentile 66.7%

Sector Context

Sector Average -0.33
Sector Median 0.63
Sector Rank #11 of 50
Sector Percentile 22.0%

SPARC P/B Ratio — Valuation Insights & Book Value Analysis

Sun Pharma Advanced Research Co price-to-book ratio interpretation, valuation status and historical context — current P/B 5.09 (High). For live price, earnings yield and the full fundamental profile, see SPARC share price.

  • Stock appears overvalued with PB of 5.09, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Current PB is 99.9% above historical average
  • Trading at premium to sector average PB of -0.33

Sun Pharma Advanced Research Co P/B Ratio Historical Trend

SPARC annual price-to-book ratio — 3 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View SPARC annual price range for the annual high/low range and current price position.

SPARC Historical P/B Ratio — Book Value Per Share & Year-End Price

Sun Pharma Advanced Research Co annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 0.55 ₹405.76 ₹221.35 ₹1,339 Low
2024 5.25 ₹38.18 ₹200.55 ₹126 High
2023 1.84 ₹155.45 ₹286.80 ₹513 Moderate

SPARC vs Healthcare Peers — P/B Ratio Comparison

Sun Pharma Advanced Research Co P/B 5.09 vs Healthcare average -0.33, median 0.63 — range -17.92–1.01.

Sector Average
-0.33
Sector Median
0.63
Lowest P/B
-17.92
Highest P/B
1.01
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Rekvina Laboratories VINRKLB -17.92 ₹22 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Parmax Pharma PARMAX -2.48 ₹14 Low
Bharat Immunologicals BIBCL -2.32 ₹76 Low
Krebs Biochemicals & Ind… KREBSBIO -0.71 ₹127 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.63 ₹53 Low